Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Clinical trial NCT01352962 · COMPLETED
Trial details
- NCT number
- NCT01352962
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-26
- Primary completion
- 2017-02-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.